Association of Maternal Age and Blood Markers for Metabolic Disease in Newborns
Pregnancy at an advanced maternal age is considered a risk factor for adverse maternal, fetal, and neonatal outcomes. Here we investigated whether maternal age could be associated with differences in the blood levels of newborn screening (NBS) markers for inborn metabolic disorders on the Recommende...
Main Authors: | Yuhan Xie, Gang Peng, Hongyu Zhao, Curt Scharfe |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/14/1/5 |
Similar Items
-
Timing of Newborn Blood Collection Alters Metabolic Disease Screening Performance
by: Gang Peng, et al.
Published: (2021-01-01) -
Perception towards newborn screening
by: Sridhar Amalakanti, et al.
Published: (2023-01-01) -
Newborn screening for lysosomal disorders in Brazil: A pilot study using customized fluorimetric assays
by: Fernanda Bender, et al. -
A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns
by: Takanori Onuki, et al.
Published: (2023-08-01) -
Newborn screening of inherited metabolic disorders by tandem mass spectrometry: past, present and future
by: G. Scaturro, et al.
Published: (2013-04-01)